Scientists at the Martinos Center for Biomedical Imaging at Massachusetts General Hospital were able — for the first time…
Articles by Magdalena Kegel
About 300 international scientists and industry leaders recently gathered in Cambridge, Massachusetts, for the Hereditary Disease Foundation‘s 10th biennial “Milton…
In recent years, Huntington’s disease has joined the group of neurodegenerative diseases characterized by aggregation of the tau protein in…
Huntexil (pridopidine), a drug candidate intended to treat Huntington’s disease movement symptoms, might have a more intricate way of acting…
Researchers at Johns Hopkins University School of Medicine have found that patients with Huntington’s disease have a deficient system…
What do people with Huntington’s disease, obsessive compulsive disorder, and ADHD have in common? The answer is the basal ganglia,…
Researchers at Massachusetts General Hospital (MGH) report they’ve identified a novel compound that could be a potential therapy strategy for Huntington’s…
Researchers at Massachusetts Institute of Technology (MIT) and Boston University have developed a system capable of rapidly analyzing…
Results from a Phase 3 clinical trial found that deutetrabenazine (SD-809), an investigational drug developed by Teva Pharmaceutical Industries, improved chorea…
Gene therapy using mesenchymal stem cells for Huntington’s disease is showing promise in mouse studies, and preparations are underway to possibly…